Status
Conditions
Treatments
About
The goal of this clinical trial is to learn how fructose ingestion affects metabolic factors in healthy adults aged 18-64, with a BMI between 19 and 30 kg/m², of any sex or gender. Specifically, the study aims to examine the impact of fructose compared to glucose on circulating metabolic factors including the soluble leptin receptor.
The main questions it aims to answer are:
How does fructose ingestion influence levels of circulating metabolic markers, including the soluble leptin receptor? Does fructose consumption have different metabolic effects compared to glucose?
Participants will:
Complete a screening phone call to review their health history and eligibility.
Attend two in-person visits at least two weeks apart, where they will:
Fast for 8 hours beforehand. Consume a beverage containing either 75g of fructose or glucose. Have blood drawn at regular intervals for up to 5 hours after consumption to measure circulating levels of metabolic markers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
8 participants in 2 patient groups
Loading...
Central trial contact
Lu Xu, MD, PhD; Mark Herman, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal